Lappe Mark's Form 4 filing
Inhibrx, Inc. · filed Oct 18, 2022
- Accession no.
- 0001739614-22-000107
- Filed
- Oct 18, 2022, 4:37 PM ET
- Trade date
- Oct 17, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $769.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lappe MarkCIK 0001366074 | Director, Officer (Chief Executive Officer) |
| Lappe Family TrustCIK 0001821266 | Other: To be Verified |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 17, 2022 | Common Stock | SSaleDisposed | −8,981 | $28.66F2 | −$257,418.81 | 2,581,271 | Indirect | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −14,006 | $29.92F4 | −$419,122.55 | 2,567,265 | Indirect | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −2,892 | $30.81F5 | −$89,089.51 | 2,564,373 | Indirect | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −121 | $31.51F6 | −$3,812.36 | 2,564,252 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The shares were sold in multiple transactions at prices ranging from $28.475 to $29.47, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F4
The shares were sold in multiple transactions at prices ranging from $29.475 to $30.47, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F5
The shares were sold in multiple transactions at prices ranging from $30.48 to $31.44, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F6
The shares were sold in multiple transactions at prices ranging from $31.48 to $31.56, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.